FILE - In this photo taken March 29, 2017, Dr. David Maloney of the Fred Hutchinson Cancer Research Center is greeted by patient Ken Shefveland, whose lymphoma was successfully treated with CAR-T cell therapy. A CAR-T cell treatment developed by Novartis Pharmaceuticals and the University of Pennsylvania has become the first type of gene therapy to hit the U.S. market 